
|Articles|June 1, 2002
Assay reassures 'not all allergens created equal'
New Orleans - Studies have shown that the local lymph node assay(LLNA) in mice can be used to provide quantitative estimates of the relativeskin sensitizing potency of various product ingredients, and these valuescorrelate closely with what is known of the ability of chemicals to causeskin sensitization in humans, G. Frank Gerberick, Ph.D., said at the annualAmerican Academy of Dermatology meeting.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
2
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial
3
Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine
4
Envudeucitinib Achieves 54% PASI 100 Rate at 48 Weeks in Phase 3 Extension
5











